WallStreetZenWallStreetZen

NASDAQ: KYMR
Kymera Therapeutics Inc Stock Ownership - Who owns Kymera Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Kymera Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Nello MainolfiChief Executive Officer2025-10-2930,000$2.08
$62.40kBuy
Nello MainolfiChief Executive Officer2025-10-291,862$59.72
$111.20kSell
Nello MainolfiChief Executive Officer2025-10-2924,511$61.02
$1.50MSell
Nello MainolfiChief Executive Officer2025-10-293,627$61.46
$222.91kSell
Jared GollobChief Medical Officer2025-10-1522,210$2.08
$46.20kBuy
Jared GollobChief Medical Officer2025-10-158,963$61.49
$551.16kSell
Jared GollobChief Medical Officer2025-10-1514,896$62.72
$934.32kSell
Jared GollobChief Medical Officer2025-10-156,453$63.09
$407.10kSell
Jared GollobChief Medical Officer2025-10-1528,999$1.31
$37.99kBuy
Jared GollobChief Medical Officer2025-10-1529,264$60.37
$1.77MSell

1 of 5

KYMR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KYMR insiders and whales buy or sell their stock.

KYMR Shareholders

What type of owners hold Kymera Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP9.24%6,651,429$426.36MInstitution
Avoro Capital Advisors LLC8.83%6,350,000$407.04MInstitution
Baker Bros Advisors LP8.50%6,117,295$392.12MInsider
Fmr LLC8.17%5,879,611$376.88MInstitution
Atlas Venture Associates X LP8.01%5,763,012$369.41MInsider
Atlas Venture Fund X LP7.65%5,504,905$352.86MInsider
Bvf Inc7.65%5,502,710$352.72MInstitution
Vanguard Group Inc7.54%5,421,722$347.53MInstitution
Wellington Management Group LLP7.22%5,195,691$333.04MInstitution
Price T Rowe Associates Inc7.08%5,097,378$326.74MInstitution

1 of 3

KYMR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KYMR76.22%23.78%Net BuyingNet Selling
PRAX63.59%36.41%Net SellingNet Selling
COGT90.45%9.55%Net Buying
AKRO74.54%25.46%Net BuyingNet Buying
NAMS74.61%25.39%Net SellingNet Selling
View Top Biotech Stocks

Kymera Therapeutics Stock Ownership FAQ

Who owns Kymera Therapeutics?

Kymera Therapeutics (NASDAQ: KYMR) is owned by 111.04% institutional shareholders, 34.65% Kymera Therapeutics insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Kymera Therapeutics shareholder, owning 6.12M shares representing 8.50% of the company. Baker Bros Advisors LP's Kymera Therapeutics shares are currently valued at $393.40M.

If you're new to stock investing, here's how to buy Kymera Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.